Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Evan Lippman
17 Aug 2026
EVP, Business Development
Sold on a plan
18,600
$36.57
$680.29K
Eliyahu Sharon Kalif
11 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
106,563
$34.10
$3.63M
Eliyahu Sharon Kalif
14 May 2026
EVP, Chief Financial Officer
Sold on a plan
153,251
$35.61
$5.46M
Eliyahu Sharon Kalif
26 Feb 2026
EVP, Chief Financial Officer
Sold on a plan
345,810
$33.64
$11.63M

What was left out

Form 4 filings counted 82
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 39
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 3,557,282
History held since 24 Jul 2008